blog trackingweb statistics

RealClearPolitics

Real Clear Politics News (2026)

Ivermectin + Mebendazole: Groundbreaking Study Reports 84.4% Clinical Benefit Rate in Cancer Patients

The following content is sponsored by The Wellness Company.

\n\n

Why Patients Are Losing Faith in Medicine — and What One New Study Is Proposing Instead

\n\n

Trust in the American healthcare system has been eroding for years, and the pandemic accelerated the decline sharply. In April 2020, nearly three-quarters of Americans, 71.5%, said they placed “a lot of trust” in doctors and hospitals. By January 2024, fewer than four years later, that figure had fallen to just 40.1%.

\n\n

The drop reflects more than pandemic fatigue. For a growing share of patients, it signals a deeper worry: that medical decisions are shaped less by what’s best for the patient and more by corporate and financial interests.

\n\n

The Wellness Company was founded on the opposite premise, that healthcare should put patients ahead of profit. That mission is now behind one of the company’s most closely watched research efforts to date: a first-of-its-kind investigation, led by Dr. Peter McCullough and colleagues, into whether the combination of Ivermectin and Mebendazole has a role to play in cancer care.

\n\n

This groundbreaking study has been peer reviewed and published in Anticancer Research, a major international oncology journal.

\n\n

Most Patients in New Analysis Reported a Clinical Benefit

\n\n

A…

Original source: https://breitbart.com/

Leave a Reply

Your email address will not be published. Required fields are marked *